|
FY2025
12 months to Aug 31, 2025
|
FY2024
12 months to Aug 31, 2024
|
FY2023
12 months to Aug 31, 2023
|
|
|---|---|---|---|
| Revenue | |||
| Expenses | |||
| Selling, general and administrative | |||
| Advertising and marketing | |||
| Salaries, wages and benefits | |||
| Interest expense and bank charges | |||
| Depreciation and amortization | |||
| Government incentive | |||
| Loss on derecognition of right of use of asset | |||
| Total expenses | |||
| Loss from operations | |||
| Write down of investment | |||
| (Loss) on extinguishment of liability | |||
| Foreign exchange gain (loss) | |||
| Gain on change in fair value of warrant liability | |||
| Gain on change in fair value of conversion feature liability | |||
| Financing cost – warrant issuance | |||
| Accretion expense | |||
| Loss before income taxes | |||
| Other income | |||
| Net loss | |||
| Foreign currency translation adjustment | |||
| Net loss and comprehensive loss | |||
| Net loss per share - basic | |||
| Net loss per share - diluted | |||
| Weighted average number of common shares outstanding - basic (Numbers) | |||
| Weighted average number of common shares outstanding - diluted (Numbers) |
Loading...
